
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Orexin supplementation in narcolepsy treatment: A review
Eugenie Nepovimová, Jana Janočková, Jan Misík, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 3, pp. 961-975
Closed Access | Times Cited: 41
Eugenie Nepovimová, Jana Janočková, Jan Misík, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 3, pp. 961-975
Closed Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
The Contribution of HCN Channelopathies in Different Epileptic Syndromes, Mechanisms, Modulators, and Potential Treatment Targets: A Systematic Review
Miriam Kessi, Jing Peng, Haolin Duan, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 28
Miriam Kessi, Jing Peng, Haolin Duan, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 28
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Effect of a dual orexin receptor antagonist on Alzheimer's disease: Sleep disorders and cognition
Mengzhen Zhou, Shi Tang
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 13
Mengzhen Zhou, Shi Tang
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 13
Computational Analysis of the Fully Activated Orexin Receptor 2 across Various Thermodynamic Ensembles with Surface Tension Monitoring and Markov State Modeling
Rafael Doležal
The Journal of Physical Chemistry B (2025)
Closed Access
Rafael Doležal
The Journal of Physical Chemistry B (2025)
Closed Access
The Orexin System and Its Impact on the Autonomic Nervous and Cardiometabolic System in Post-Acute Sequelae of COVID-19
Jana Ruhrländer, Styliani Syntila, Elisabeth Schieffer, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 545-545
Open Access
Jana Ruhrländer, Styliani Syntila, Elisabeth Schieffer, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 545-545
Open Access
Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study
Susana Lozano-Tovar, Riccardo Cremascoli, Marzia Nuccetelli, et al.
Neurological Sciences (2025)
Open Access
Susana Lozano-Tovar, Riccardo Cremascoli, Marzia Nuccetelli, et al.
Neurological Sciences (2025)
Open Access
Disrupted topological properties of structural brain networks present a glutamatergic neuropathophysiology in people with narcolepsy
Guoyan Chen, Wen Wang, Haoyang Wu, et al.
SLEEP (2024) Vol. 47, Iss. 6
Open Access | Times Cited: 4
Guoyan Chen, Wen Wang, Haoyang Wu, et al.
SLEEP (2024) Vol. 47, Iss. 6
Open Access | Times Cited: 4
The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target
Fan Gao, Tao Liu, Miao Tuo, et al.
Neuroscience Letters (2021) Vol. 765, pp. 136247-136247
Closed Access | Times Cited: 22
Fan Gao, Tao Liu, Miao Tuo, et al.
Neuroscience Letters (2021) Vol. 765, pp. 136247-136247
Closed Access | Times Cited: 22
Prevalence and Clinical Characteristics of Sleeping Paralysis: A Systematic Review and Meta-Analysis
Mahmoud Tarek Hefnawy, Basma Ehab Amer, Samar A. Amer, et al.
Cureus (2024)
Open Access | Times Cited: 2
Mahmoud Tarek Hefnawy, Basma Ehab Amer, Samar A. Amer, et al.
Cureus (2024)
Open Access | Times Cited: 2
A direct estrogenic involvement in the expression of human hypocretin
Haimei Li, Xinlu Chen, Jingyi Dong, et al.
Life Sciences (2024) Vol. 344, pp. 122581-122581
Open Access | Times Cited: 2
Haimei Li, Xinlu Chen, Jingyi Dong, et al.
Life Sciences (2024) Vol. 344, pp. 122581-122581
Open Access | Times Cited: 2
Orexinergic System in Neurodegenerative Diseases
Qinqin Wang, Fei Cao, Yili Wu
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 16
Qinqin Wang, Fei Cao, Yili Wu
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 16
Pitolisant for treating patients with narcolepsy
Shuang Li, Junyi Yang
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 2, pp. 79-84
Closed Access | Times Cited: 16
Shuang Li, Junyi Yang
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 2, pp. 79-84
Closed Access | Times Cited: 16
An overview of the orexinergic system in different animal species
Idris A. Azeez, Olumayowa O. Igado, James Olukayode Olopade
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1419-1444
Closed Access | Times Cited: 13
Idris A. Azeez, Olumayowa O. Igado, James Olukayode Olopade
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1419-1444
Closed Access | Times Cited: 13
Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy
Junyi Yang, Junfa Gao
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 8, pp. 723-728
Closed Access | Times Cited: 15
Junyi Yang, Junfa Gao
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 8, pp. 723-728
Closed Access | Times Cited: 15
Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy
Laura Pérez‐Carbonell
Current Treatment Options in Neurology (2019) Vol. 21, Iss. 11
Closed Access | Times Cited: 14
Laura Pérez‐Carbonell
Current Treatment Options in Neurology (2019) Vol. 21, Iss. 11
Closed Access | Times Cited: 14
Cannabidiol Partially Blocks the Excessive Sleepiness in Hypocretindeficient Rats: Preliminary Data
Eric Murillo-Rodrı́guez, Diana Millán‐Aldaco, Marcela Palomero‐Rivero, et al.
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 9, pp. 705-712
Closed Access | Times Cited: 13
Eric Murillo-Rodrı́guez, Diana Millán‐Aldaco, Marcela Palomero‐Rivero, et al.
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 9, pp. 705-712
Closed Access | Times Cited: 13
Computational Analysis of Fully Activated Orexin Receptor 2 Across Various Thermodynamic Ensembles with Surface Tension Monitoring
Rafael Doležal
(2024)
Open Access | Times Cited: 1
Rafael Doležal
(2024)
Open Access | Times Cited: 1
Neurophysiology and Treatment of Disorders of Consciousness Induced by Traumatic Brain Injury: Orexin Signaling as a Potential Therapeutic Target
Huiling Tang, Qiumei Zhu, Wei Li, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 39, pp. 4208-4220
Closed Access | Times Cited: 11
Huiling Tang, Qiumei Zhu, Wei Li, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 39, pp. 4208-4220
Closed Access | Times Cited: 11
<p>Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects</p>
Ashima Sahni, Melissa Carlucci, Malik Malik, et al.
Nature and Science of Sleep (2019) Vol. Volume 11, pp. 241-252
Open Access | Times Cited: 9
Ashima Sahni, Melissa Carlucci, Malik Malik, et al.
Nature and Science of Sleep (2019) Vol. Volume 11, pp. 241-252
Open Access | Times Cited: 9
Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods
Jana Janočková, Rafael Doležal, Eugenie Nepovimová, et al.
Molecules (2018) Vol. 23, Iss. 11, pp. 2926-2926
Open Access | Times Cited: 8
Jana Janočková, Rafael Doležal, Eugenie Nepovimová, et al.
Molecules (2018) Vol. 23, Iss. 11, pp. 2926-2926
Open Access | Times Cited: 8
From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia
Eva Mezeiová, Jana Janočková, Jan Konečný, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104179-104179
Closed Access | Times Cited: 6
Eva Mezeiová, Jana Janočková, Jan Konečný, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104179-104179
Closed Access | Times Cited: 6
Regulatory effect of orexin system on various diseases through mTOR signaling pathway
Ying Song, Beibei Wang, Wenjun Wang, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 5, pp. 292-302
Open Access | Times Cited: 2
Ying Song, Beibei Wang, Wenjun Wang, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 5, pp. 292-302
Open Access | Times Cited: 2
The effects of different dosages of dual orexin receptor antagonists and zolpidem on sleep and cognitive function: A meta-analysis and systematic review
Mengzhen Zhou, Rujia Liu, Zhengqi Xie
Sleep Epidemiology (2023) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 2
Mengzhen Zhou, Rujia Liu, Zhengqi Xie
Sleep Epidemiology (2023) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 2
Involvement of orexin type-2 receptors in genetic absence epilepsy rats
Aylin Toplu, Nursima Mutlu, Elif Tuğçe Erdeve, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 2
Aylin Toplu, Nursima Mutlu, Elif Tuğçe Erdeve, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 2